200 related articles for article (PubMed ID: 23552696)
1. Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells.
Shimura T; Noma N; Oikawa T; Ochiai Y; Kakuda S; Kuwahara Y; Takai Y; Takahashi A; Fukumoto M
Oncogenesis; 2012 Jun; 1(6):e12. PubMed ID: 23552696
[TBL] [Abstract][Full Text] [Related]
2. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
3. Targeting the AKT/cyclin D1 pathway to overcome intrinsic and acquired radioresistance of tumors for effective radiotherapy.
Shimura T
Int J Radiat Biol; 2017 Apr; 93(4):381-385. PubMed ID: 27910734
[TBL] [Abstract][Full Text] [Related]
4. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression.
Shimura T; Kakuda S; Ochiai Y; Nakagawa H; Kuwahara Y; Takai Y; Kobayashi J; Komatsu K; Fukumoto M
Oncogene; 2010 Aug; 29(34):4826-37. PubMed ID: 20562919
[TBL] [Abstract][Full Text] [Related]
5. Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle.
Shimura T
J Radiat Res; 2011; 52(5):539-44. PubMed ID: 21881296
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells.
Shimura T; Ochiai Y; Noma N; Oikawa T; Sano Y; Fukumoto M
Cell Cycle; 2013 Mar; 12(5):773-82. PubMed ID: 23388457
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 promotes radioresistance through regulation of RAD51 in melanoma.
Im H; Lee J; Lee HJ; Kim DY; Kim EJ; Yi JY
Exp Dermatol; 2023 Oct; 32(10):1706-1716. PubMed ID: 37421206
[TBL] [Abstract][Full Text] [Related]
8. Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma
Yu CC; Hung SK; Lin HY; Chiou WY; Lee MS; Liao HF; Huang HB; Ho HC; Su YC
Oncotarget; 2017 Sep; 8(40):68641-68653. PubMed ID: 28978144
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
10. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect and mechanism of Yi-qi-hua-yu-jie-du decoction on the drug resistance of gastric cancer stem cells based on ABC transporters.
Huang W; Wen F; Gu P; Liu J; Xia Y; Li Y; Zhou J; Song S; Ruan S; Gu S; Chen X; Shu P
Chin Med; 2022 Aug; 17(1):93. PubMed ID: 35941687
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DLGAP1-AS2 promotes the radioresistance of rectal cancer stem cells by upregulating CD151 expression via E2F1.
Xiao SY; Yan ZG; Zhu XD; Qiu J; Lu YC; Zeng FR
Transl Oncol; 2022 Apr; 18():101304. PubMed ID: 35144091
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
[TBL] [Abstract][Full Text] [Related]
14. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
15. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
[TBL] [Abstract][Full Text] [Related]
16. DNA damage signaling guards against perturbation of cyclin D1 expression triggered by low-dose long-term fractionated radiation.
Shimura T; Kobayashi J; Komatsu K; Kunugita N
Oncogenesis; 2014 Dec; 3(12):e132. PubMed ID: 25486524
[TBL] [Abstract][Full Text] [Related]
17. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells.
Su H; Jin X; Shen L; Fang Y; Fei Z; Zhang X; Xie C; Chen X
Tumour Biol; 2016 Apr; 37(4):5355-63. PubMed ID: 26561473
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cyclin D1/CDK4 and pRb mediated by PI3K/AKT pathway activation in Pb2+ -induced neuronal death in cultured hippocampal neurons.
Li C; Xing T; Tang M; Yong W; Yan D; Deng H; Wang H; Wang M; Chen J; Ruan D
Toxicol Appl Pharmacol; 2008 Jun; 229(3):351-61. PubMed ID: 18353414
[TBL] [Abstract][Full Text] [Related]
20. Radiation-Activated PI3K/AKT Pathway Promotes the Induction of Cancer Stem-Like Cells via the Upregulation of SOX2 in Colorectal Cancer.
Park JH; Kim YH; Shim S; Kim A; Jang H; Lee SJ; Park S; Seo S; Jang WI; Lee SB; Kim MJ
Cells; 2021 Jan; 10(1):. PubMed ID: 33445526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
